Sean Brynjelsen

President & CEO, Director, Eton Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$9.9M

Companies

Latest trade

Aug 20, 2026

Companies

Eton Pharmaceuticals, Inc.President & CEO, Director −$9.9M

Trades

ETON Sold 91,022 shares at $60.70 $5.5M Aug 20

ETON Sold 8,978 shares at $62.65 $0.6M Aug 19

ETON Sold 120,000 shares at $31.88 $3.8M May 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.